Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

For more than 20 years, the Duke Consortia for HIV/AIDS Vaccine Development had conducted its groundbreaking research with ...

Infectious disease experts have hailed a move that will see a highly effective HIV prevention drug be sold at just 40 dollars ...

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Close monitoring of HIV viral load is crucial to prevent LLV among HIV-positive patients on ART, particularly older adults with low CD4+ counts and a history of PI use.

Advances in HIV medication, its window of detection and its transmission risk within the last decade have led to an updated ...